Aclaris Therapeutics, Inc. (ACRS)
4.76
+2.14
(+81.68%)
USD |
NASDAQ |
Jan 20, 14:53
Aclaris Therapeutics Market Cap: 515.72M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.663B |
| Puma Biotechnology, Inc. | 326.53M |
| Nephros, Inc. | 53.13M |
| Prelude Therapeutics, Inc. | 120.07M |
| Vivos Therapeutics, Inc. | 17.98M |
Market Cap Related Metrics
| PS Ratio | 34.99 |
| PEG Ratio | -0.0207 |
| Price to Book Value | 4.294 |
| Price | 4.76 |
| Earnings Yield | -29.02% |
| PEGY Ratio | -0.0207 |